GARS, median (IQR)a | | | | |
Baselineb | 33 (27 to 43) | 25 (20 to 34) | 30 (23 to 37) | 30 (25 to 38) |
Follow-up | 29 (23 to 38) | 26 (21 to 35) | 33 (26 to 41) | 41 (35 to 51) |
Deltab | −3 (−5 to −2) | 0 (0 to 1) | 3 (2 to 4) | 9 (7 to 12) |
|
eFI-U, median (IQR) | | | | |
Baseline | 0.16 (0.10 to 0.22) | 0.14 (0.08 to 0.18) | 0.16 (0.12 to 0.22) | 0.18 (0.10 to 0.22) |
Follow-up | 0.18 (0.12 to 0.24) | 0.16 (0.10 to 0.20) | 0.18 (0.12 to 0.24) | 0.18 (0.14 to 0.26) |
Deltab | 0.02 (0.00 to 0.04) | 0.02 (0.00 to 0.04) | 0.02 (0.00 to 0.06) | 0.02 (0.00 to 0.04) |
|
Major medical events, n (%)b | 50 (13.0) | 29 (10.0) | 42 (11.6) | 72 (20.5) |